Meeting to be held in Boston on February 24 hosted by Truist.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VRTX:
- Crispr Therapeutics price target lowered to $123 from $153 at Chardan
- Entrada Therapeutics closes agreement with Vertex
- Vertex Pharmaceuticals price target lowered to $365 from $374 at SVB Securities
- Vertex Pharmaceuticals price target raised to $325 from $300 at H.C. Wainwright
- Vertex Pharmaceuticals price target raised to $342 from $313 at Barclays